NO985534L - Oppl°sbare oksider for biologiske anvendelser - Google Patents

Oppl°sbare oksider for biologiske anvendelser

Info

Publication number
NO985534L
NO985534L NO985534A NO985534A NO985534L NO 985534 L NO985534 L NO 985534L NO 985534 A NO985534 A NO 985534A NO 985534 A NO985534 A NO 985534A NO 985534 L NO985534 L NO 985534L
Authority
NO
Norway
Prior art keywords
biological applications
soluble oxides
xerogel
silica
gel
Prior art date
Application number
NO985534A
Other languages
English (en)
Other versions
NO328711B1 (no
NO985534D0 (no
Inventor
Manja Ahola
Heidi Fagerholm
Ilkka Kangasniemi
Juha Kiesvaara
Pirjo Kortesuo
Kauko Kurkela
Niilo Saarinen
Antti Yli-Urpo
Original Assignee
Orion Corp
Bioxid Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26691266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO985534(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp, Bioxid Oy filed Critical Orion Corp
Publication of NO985534D0 publication Critical patent/NO985534D0/no
Publication of NO985534L publication Critical patent/NO985534L/no
Publication of NO328711B1 publication Critical patent/NO328711B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/10—Ceramics or glasses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/16—Preparation of silica xerogels
    • C01B33/163—Preparation of silica xerogels by hydrolysis of organosilicon compounds, e.g. ethyl orthosilicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Ceramic Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Silicon Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19985534A 1996-05-29 1998-11-27 Anvendelse av en silika-xerogel for fremstilling av en avleveringsanordning med langsom frigjoring, avleveringsanordningen, farmasoytisk preparat som omfatter denne, samt anvendelse av silika-xerogel for fremstilling av en avleveringsanordning for administrering av et biologisk aktivt middel NO328711B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1857596P 1996-05-29 1996-05-29
US4242397P 1997-03-27 1997-03-27
PCT/FI1997/000330 WO1997045367A1 (en) 1996-05-29 1997-05-29 Dissolvable oxides for biological applications

Publications (3)

Publication Number Publication Date
NO985534D0 NO985534D0 (no) 1998-11-27
NO985534L true NO985534L (no) 1999-01-26
NO328711B1 NO328711B1 (no) 2010-05-03

Family

ID=26691266

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985534A NO328711B1 (no) 1996-05-29 1998-11-27 Anvendelse av en silika-xerogel for fremstilling av en avleveringsanordning med langsom frigjoring, avleveringsanordningen, farmasoytisk preparat som omfatter denne, samt anvendelse av silika-xerogel for fremstilling av en avleveringsanordning for administrering av et biologisk aktivt middel

Country Status (18)

Country Link
EP (2) EP1618896A3 (no)
JP (1) JP4322315B2 (no)
CN (1) CN1103320C (no)
AT (1) ATE301102T1 (no)
AU (1) AU738176B2 (no)
CA (1) CA2257172C (no)
CZ (1) CZ297042B6 (no)
DE (1) DE69733889T3 (no)
DK (1) DK0906243T4 (no)
EE (1) EE03758B1 (no)
ES (1) ES2244998T5 (no)
HU (1) HU227939B1 (no)
NO (1) NO328711B1 (no)
NZ (1) NZ332968A (no)
PL (1) PL330191A1 (no)
RU (1) RU2208582C2 (no)
SK (1) SK284193B6 (no)
WO (1) WO1997045367A1 (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980032A0 (fi) * 1998-01-09 1998-01-09 Heikki Matti Eemeli Rauvala Ny anvaendning av en heparin bindande, med tillvaext foerknippad molekyl
FI109332B (fi) 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
IL138990A0 (en) 1999-02-12 2001-11-25 Biostream Inc Matrices for drug delivery and methods for making and using the same
AU764663C (en) * 1999-02-22 2005-02-03 Bayer Innovation Gmbh Biodegradable ceramic fibres from silica sols
FI19991806A7 (fi) * 1999-08-25 2001-02-26 Yli Urpo Antti Uusia koostumuksia biologisesti aktiivisen aineen säädettyyn vapauttamiseen, ja niiden valmistus
US6632412B2 (en) 1999-12-01 2003-10-14 Timo Peltola Bioactive sol-gel derived silica fibers and methods for their preparation
AUPQ573300A0 (en) 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
ES2366886T1 (es) 2000-04-21 2011-10-26 Sol-Gel Technologies Ltd. Composición que presenta estabilidad de formulación potenciada y administración de ingredientes activos tópicos potenciado.
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
WO2002080977A1 (en) * 2001-04-04 2002-10-17 Delsitech Oy Biodegradable carrier and method for preparation thereof
JP4199545B2 (ja) * 2001-04-27 2008-12-17 ビボキシド オサケユイチア 軟組織付着の改善方法、および移植片作製のための該方法の使用
US8580291B2 (en) * 2002-03-15 2013-11-12 The Trustees Of The University Of Pennsylvania Fibrous composite for tissue engineering
CN100408026C (zh) * 2003-01-24 2008-08-06 纽约州立大学研究基金会 用于包裹光动力学疗法治疗剂的陶瓷纳米微粒及其使用方法
JP2007500590A (ja) 2003-07-31 2007-01-18 ゾル−ゲル テクノロジーズ エルティーディー． 活性成分が充填されたマイクロカプセル及びその製造方法
AU2005217169B2 (en) * 2004-02-27 2011-09-01 Delsitech Oy Method for preparing adjustably bioresorbable sol-gel derived SiO2
EP1602365A1 (en) * 2004-03-03 2005-12-07 Switch Biotech Aktiengesellschaft Pharmaceutical composition for topical use in form of xerogels or films and methods for production
GB0420016D0 (en) 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system
JP4006002B2 (ja) * 2004-11-26 2007-11-14 キヤノン株式会社 Ｄｎａ担持繊維及びｄｎａ担持繊維シート並びにこれらの製造方法
EA015815B1 (ru) 2005-08-02 2011-12-30 Сол-Джел Текнолоджиз Лтд. Покрытие из оксида металла для водонерастворимых ингредиентов
WO2007036939A2 (en) 2005-09-27 2007-04-05 Sol-Gel Technologies Ltd. Methods for crop protection
WO2007129991A1 (en) 2006-05-04 2007-11-15 Agency For Science Technology And Research Mechanically reversible gel
US8343514B2 (en) * 2006-06-06 2013-01-01 Universidad Autonome Metropolitana Sol-gel nanostructured titania reservoirs for use in the controlled release of drugs in the central nervous system and method of synthesis
JP2010505883A (ja) 2006-10-12 2010-02-25 ザ ユニバーシティー オブ クイーンズランド 免疫応答を調節するための組成物および方法
DE102007061873B4 (de) * 2007-01-15 2025-06-26 Bayer Intellectual Property Gmbh Kieselsol-Material zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien, dessen Herstellung und Verwendung
AU2008211554B2 (en) 2007-02-01 2013-12-19 Sol-Gel Technologies Ltd. Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
FI20070174A0 (fi) * 2007-02-28 2007-02-28 Delsitech Oy Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
JP5344417B2 (ja) * 2007-04-17 2013-11-20 国立大学法人群馬大学 水油界面を利用した薬物−シリカ封入体の製造法
DE102007026043B4 (de) * 2007-06-04 2018-08-16 Jiangsu Synecoun Medical Technology Co., Ltd. Nicht-toxisches Polyethoxysiloxan-Material zur Herstellung von biologisch resorbierbares und/oder bioaktives Polyethoxysiloxan-Material enthaltenden Artikeln, dessen Herstellung und Verwendung
DE102007061874A1 (de) * 2007-12-19 2009-06-25 Bayer Innovation Gmbh Nicht-toxisches Polysiloxan-Material zur Herstellung von biologisch resorbierbaren und/oder bioaktiven Polysiloxan-Material enthaltenden Artikeln, dessen Herstellung und Verwendung
DE102008033327A1 (de) * 2008-07-16 2010-01-21 Bayer Innovation Gmbh Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik
DE102009053784A1 (de) * 2009-11-19 2011-05-26 BSH Bosch und Siemens Hausgeräte GmbH Verfahren zur Herstellung eines porösen SiO2-Xerogels mit charakteristischer Porengröße durch ein Bottom-Up-Verfahren über eine Vorstufe mit organischen Festkörperskelettstützen
DE102009053782A1 (de) * 2009-11-19 2011-06-01 BSH Bosch und Siemens Hausgeräte GmbH Poröses SiO2-Xerogel mit charakteristischer Porengröße, dessen trocknungsstabile Vorstufen und dessen Anwendung
US8901185B2 (en) * 2010-04-12 2014-12-02 Universite Claude Bernard Lyon I Hybrid organic-inorganic material constituted by a silica network having photochromic agents and optical power limiting agents as a doping agent in the material
EP2417982A1 (en) * 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
DE102010034695A1 (de) * 2010-08-18 2012-02-23 Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V. Xerogele mit homogen eingebetteten Lebensmittelzusätzen und Verfahren zur ihrer Herstellung
BR112013010926A2 (pt) 2010-11-01 2016-08-23 Univ Technology Sidney agentes imunomoduladores e seus usos
AU2012352528B9 (en) 2011-12-11 2017-11-02 Baudax Bio, Inc. Intranasal dexmedetomidine compositions and methods of use thereof
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
CA2912483C (en) * 2013-06-24 2021-06-15 Delsitech Oy Silica hydrogel composite
CN104546804A (zh) * 2013-10-09 2015-04-29 上海现代药物制剂工程研究中心有限公司 三维网状立体构型的透皮给药制剂及其制备方法
LT3365020T (lt) 2015-10-22 2019-10-25 Delsitech Oy Hidrogelio kompozicijos depo vaisto forma
CA3069359C (en) 2017-07-12 2023-01-10 Sol-Gel Technologies Ltd. Compositions comprising encapsulated tretinoin
GR1010001B (el) * 2019-12-30 2021-05-12 Πυρογενεσις Αβεε Υδρογελες και ξηρογελες φορεις δραστικων συστατικων αποτελουμενες απο δενδριτικα πολυμερη και πυριτια για εφαρμογες επικαλυψης σε στερεα υποστρωματα

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3846537A (en) * 1972-08-21 1974-11-05 Monsanto Co Process of preparing silica xerogels
JPH0764543B2 (ja) * 1987-07-24 1995-07-12 富士デヴィソン化学株式会社 球状シリカ及びその製法
IT1216570B (it) * 1988-04-08 1990-03-08 Vectorpharma Int Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
US5200334A (en) * 1991-08-13 1993-04-06 The Regents Of The University Of California Sol-gel encapsulated enzyme
EP0680753A3 (de) * 1994-05-06 1996-08-28 Feinchemie Gmbh Sebnitz Metalloxidkomposit mit steuerbarer Wirkstoffabgabe.
DE4422912A1 (de) * 1994-06-30 1996-01-11 Hoechst Ag Xerogele, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
US5591453A (en) * 1994-07-27 1997-01-07 The Trustees Of The University Of Pennsylvania Incorporation of biologically active molecules into bioactive glasses

Also Published As

Publication number Publication date
ES2244998T3 (es) 2005-12-16
HUP9903865A3 (en) 2000-06-28
DK0906243T4 (da) 2009-06-08
PL330191A1 (en) 1999-04-26
EE03758B1 (et) 2002-06-17
NO328711B1 (no) 2010-05-03
CA2257172C (en) 2005-04-12
DE69733889T3 (de) 2009-10-22
EE9800418A (et) 1999-10-15
CN1219919A (zh) 1999-06-16
EP1618896A2 (en) 2006-01-25
HU227939B1 (en) 2012-06-28
DK0906243T3 (da) 2005-10-03
SK164298A3 (en) 1999-11-08
CZ297042B6 (cs) 2006-08-16
WO1997045367A1 (en) 1997-12-04
RU2208582C2 (ru) 2003-07-20
HUP9903865A1 (hu) 2000-04-28
EP0906243B2 (en) 2009-04-01
SK284193B6 (sk) 2004-10-05
CA2257172A1 (en) 1997-12-04
JP4322315B2 (ja) 2009-08-26
AU738176B2 (en) 2001-09-13
DE69733889D1 (de) 2005-09-08
NO985534D0 (no) 1998-11-27
AU2964197A (en) 1998-01-05
ATE301102T1 (de) 2005-08-15
CZ384598A3 (cs) 1999-07-14
DE69733889T2 (de) 2006-04-13
EP0906243B1 (en) 2005-08-03
JP2001509122A (ja) 2001-07-10
CN1103320C (zh) 2003-03-19
NZ332968A (en) 2000-08-25
EP0906243A1 (en) 1999-04-07
EP1618896A3 (en) 2010-07-14
ES2244998T5 (es) 2009-06-15

Similar Documents

Publication Publication Date Title
NO985534D0 (no) Oppl°sbare oksider for biologiske anvendelser
DE19580865D2 (de) Implantat, Implantationsverfahren und Applikationsvorrichtung
AU2002231058A1 (en) Biologically active agent delivery apparatus and method
WO1997014806A3 (en) Delivery of biologically active polypeptides
AU9278898A (en) Process for preparing biologically compatible polymers and their use in medical devices
GB9626513D0 (en) A pharmaceutical composition
FI965203A0 (fi) Morfiinia, polypyrrolidonia ja polyalkyleenioksidia sisältävä koostumus
AU3593597A (en) Medical adhesive bandage, delivery system and method
ATE547136T1 (de) Therapievorrichtung für wunden
BR9609176A (pt) Composi-{es de agente biolÄgico
EP0953320A3 (en) Medical device
AU4871099A (en) Stent delivery device and method of use
AU1970495A (en) Drug delivery device and method of construction
MXPA03010295A (es) Sistema para administrar productos cosmeticos y farmaceuticos.
BR9501319A (pt) Composição tópica cosmetica e/ou dermatológica utilização desta composição e processo de tratamento cosmético
AU5456894A (en) Polysiloxanes having fluoroaliphatic- and carboxyl-containing terminal groups, their preparation, and their use in treatment of fibrous substrates
DK0543868T3 (da) Sårovertrækssystem
EP0145210A3 (en) Support particles coated with precursors biologically active glass
IS1930B (is) Notkun samsetningar H+, K+ -ATPasa tálma og sykurstera í meðhöndlun á nefsepagerum
AU2658195A (en) Immobilization of biologically active materials and diagnostic agents in cross-linked poly(organophosphazenes)
HUT74608A (en) Biologically active silicon-compounds and their pharmaceutical and cosmetical use
IT1293088B1 (it) Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in
ES2019025A6 (es) Procedimiento para preparar una composicion farmaceutica liquida de desmopresina.
RU96110609A (ru) Способ лечения посттравматической внутриглазной инфекции
RU95105648A (ru) Средство для лечения ран

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees